SIGA Technologies, Inc.

Common Stock SEC Reporting - Current
Pink Current Information
Verified Company Profile 4/10/2017
Contact Info
  • 27 East 62 nd Street
  • New York, NY 10065

Business Description

Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Mar 31, 2017 10-Q
CIK 0001010086
Fiscal Year End 12/31
OTC Marketplace Pink Current
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: DE, USA
Year of Inc. 1995
Employees 36 a/o Mar 02, 2017
Company Officers/Contacts
Phillip L Gomez CEO
Daniel J. Luckshire CFO, EVP, EVP, Fin.
Dennis E. Hruby CSO
Company Directors
James J. Antal
Michael J. Bayer
Thomas E. Constance
Joseph W. Marshall, III
Jeffrey B. Kindler
Paul G. Savas
Bruce Slovin
Andrew L. Stern
Service Providers
Accounting/Auditing Firm
300 Madison Avenue
24th Floor
New York, NY, 10017
United States
Securities Counsel

Not Available
Investor Relations Firm
KCSA Strategic Communications
880 3rd Avenue
6th Floor
New York, NY, 10022
United States
Company History
  • Note = On September 16, 2014, the company filed a voluntary petition for relief under chapter 11 of the United States Bankruptcy Code in the United States Bankruptcy Court for the Southern District of New York , Case No. 14-12623.
  • Formerly=SIGA Pharmaceuticals, Inc. until 2-00
SIGA Security Details
Share Structure
Market Value1 $245,793,784 a/o Jun 23, 2017
Authorized Shares 600,000,000 a/o Oct 10, 2016
Outstanding Shares 78,780,059 a/o Feb 28, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float Not Available
Par Value 0.0001
Shareholders of Record 36 a/o Mar 07, 2017
Short Selling Data
Short Interest 341,852 (-1.99%)
May 15, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security